Nascent preplatelets and B4GALT1 glycosylation contribute to 5-FU-induced bone marrow recovery

Natalia Weich1, Leonardo Rivadeneyra1, Alejandro Roisman1

  • 1Translational Glycomics Center, Versiti Blood Research Institute, Milwaukee, WI.

Blood Advances
|May 27, 2026
PubMed

Insights

Newly discovered preplatelets and extracellular matrix proteins aid bone marrow recovery after injury. The enzyme B4GALT1 is crucial for megakaryocyte function and platelet production, impacting hematopoietic recovery.

Area of Science:

  • Hematology
  • Cell Biology
  • Biochemistry

Background:

  • Megakaryocytes (MKs) are vital for hemostasis, vascular integrity, and supporting hematopoietic stem and progenitor cells (HSPCs).
  • The role of MKs and their products in bone marrow (BM) recovery following injury is not well understood.
  • A 5-fluorouracil (5-FU) model is used to investigate BM recovery mechanisms.

Purpose of the Study:

  • To identify the role of megakaryocytes and platelet intermediates in bone marrow recovery after chemotherapy-induced injury.
  • To investigate the function of B4GALT1 in megakaryocyte integrity and platelet production.
  • To understand the molecular mechanisms underlying hematopoietic recovery.

Main Methods:

  • Utilized a 5-fluorouracil (5-FU) induced bone marrow injury model in mice.
  • Analyzed the intramedullary space composition and dynamics during injury and recovery.
  • Employed platelet depletion and genetic knockout (B4GALT1⁻/⁻) strategies.
  • Performed single-cell transcriptomic analysis on MK-biased HSPCs.

Main Results:

  • Identified a transient intramedullary space containing extracellular matrix (ECM) proteins and preplatelets, crucial for BM recovery.
  • Platelet depletion delayed intramedullary space restoration, highlighting the role of nascent platelets.
  • Mice lacking B4GALT1 showed persistent thrombocytopenia, abnormal MKs, and delayed hematopoietic recovery.
  • B4GALT1 deficiency disrupted MK-biased HSPC programs related to adhesion, cytoskeleton, and Notch1 signaling.

Conclusions:

  • Locally retained platelet intermediates and ECM components play a critical, previously unrecognized role in bone marrow recovery.
  • B4GALT1-dependent glycosylation is essential for maintaining megakaryocyte integrity and platelet production.
  • Proper MK function and platelet generation are key determinants of hematopoietic recovery after myeloablation.